Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1186/s40545-020-00222-6 http://scihub22266oqcxt.onion/10.1186/s40545-020-00222-6 32454981!7229878!32454981     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32454981&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Pharm+Policy+Pract 2020 ; 13 (ä): 16 Nephropedia Template TP {{tp|p=32454981|t=2020. Current regulatory approaches for accessing potential COVID-19 therapies |pdf=|usr=}}{{32454981}} gab.com Text Current regulatory approaches for accessing potential COVID-19 therapies JO: J Pharm Policy Pract http://www.kidney.de/pget.php?&tw=1&pmid=32454981 #FOAvip This commentary aims to elaborate challenges in the regulatory approaches for accessing and investigating COVID-19 potential therapies either with off-label use, compassionate use, emergency use or for clinical trials. Since no therapies have been formally approved and completely effective and safe to date, the best clinical choice is acquired only after consistent and fair communication and collaboration between licensed clinicians, researchers, regulatory authorities, manufacturers and patients. Twit Text FOAVip Current regulatory approaches for accessing potential COVID-19 therapies ????J Pharm Policy Pract http://www.kidney.de/pget.php?&tw=1&pmid=32454981 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32454981 #FOAvip English Wikipedia <ref>{{Cite pmid|32454981}}</ref> Current regulatory approaches for accessing potential COVID-19 therapies #MMPMID32454981 Halimi V; Daci A; Stojanovska S; Panovska-Stavridis I; Stevanovic M; Filipce V; Grozdanova A J Pharm Policy Pract 2020[]; 13 (ä): 16 PMID32454981show ga This commentary aims to elaborate challenges in the regulatory approaches for accessing and investigating COVID-19 potential therapies either with off-label use, compassionate use, emergency use or for clinical trials. Since no therapies have been formally approved and completely effective and safe to date, the best clinical choice is acquired only after consistent and fair communication and collaboration between licensed clinicians, researchers, regulatory authorities, manufacturers and patients. äCurrent regulatory approaches for accessing potential COVID-19 therapi(epmc).pdf DeepDyve Pubget Overpricing